复方中药的国际化发展策略

摘要

复方中药作为传统中医药走向国际的名片,迟迟得不到国际社会的广泛认可与接受,20年来中药国际化尚未取得实质性进展,如何推动复方中药国际化是大家一直关心和探讨的问题.本文从遴选名方验方,提升质量标准,展示临床证据,解析毒效机制,联合产学研资,优选战略路径提出多方面思考,随着更多的中药复方制剂大品种走出国门,我们有理由相信复方中药终会以国内外临床和市场的良好口碑赢得国际认可.%As a name card of traditional Chinese medicine stepping onto the global stage,Chinese herbal compound (CHC) is hardly recognized and accepted internationally in the past 20 years.The promotion of CHC into international market has become a great concern.This article offered solutions from six aspects:developing new patent medicine based on classic formula and empirical formula,promoting drug quality standards,presenting clinical evidence,dissecting the mechanism of adverse effects and therapeutic efficacy,building alliances that combine the resources of medical research institutions and pharmaceutical enterprises,as well as optimizing strategic route.With increasing commonly used kinds of CHC going global,CHC is believed to be recognized and accepted worldwide through its clinical efficacy abroad and at home and its reputation in market.